RE:RE:RE:RE:RE:RE:RE:Ground Hog Day...Hi Science First. Believe that a number of things control the market reaction.
In the case of a small Biotech allegedly possessing a disruptive technology in the form of a compound that can be injected intravenously to selectively accumulate in deep-seated cancers (even in the brain) and then be activated more than once if necessary withinin a therapeutic window to destroy said cancers with or without adjuvants (vaccine cannabinoids, CLT etc.) by the use of low dose x-ray then would suggest that a regular updating on the progress to the Clinic of such a therapy would be one of them.
Won`t speculate on what might or might not motivate any given individual or Corporate entity to behave in any particular way but think - as witness today - that the Company is seen by the Market as a one-trick pony for NMIBC. Maybe time to start praying that this is not in fact so?